Suppr超能文献

碘化造影剂所致过敏反应的药理学预防:一项系统评价与荟萃分析

Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis.

作者信息

Hsieh Chen, Wu Shan Chia, Kosik Russell Oliver, Huang Yu-Chen, Chan Wing P

机构信息

Department of Family Medicine, Taipei City Hospital, Heping Fuyou Branch, Taipei 100058, Taiwan.

Department of Radiology, Wan Fang Hospital, Taipei Medical University, Taipei 116079, Taiwan.

出版信息

Diagnostics (Basel). 2022 Jul 9;12(7):1673. doi: 10.3390/diagnostics12071673.

Abstract

Objectives: Hypersensitivity reactions (HSRs) are uncommon but serious adverse events following the administration of iodinated contrast media (ICM) prior to CT imaging. While premedication is almost universally given in high-risk patients, there is a lack of evidence regarding the efficacy of such premedication. This study aims to determine the efficacy of premedication with corticosteroids prior to ICM administration in the prevention of HSRs through meta-analysis. Materials and Methods: An extensive review of the literature yielded 404 potentially relevant studies. Of these, five studies met the inclusion criteria of this meta-analysis. Pooled HSR event rates were obtained from each of the studies for both patients who had and who had not received premedication with corticosteroids. Heterogeneity between studies was also determined. Results: A total of 736 patients across all five studies were included in the analysis. Patients who did not receive premedication had initial pooled HSR rates of 0.16 (95% CI, 0.07−0.35) across all studies. Following premedication, pooled HSR rates dropped to 0.02 (95% CI, 0.01−0.06). Patients who had prior HSRs were significantly less likely to experience HSRs (OR = 0.09; 95% CI, 0.03−0.25; p < 0.00001) after treatment with premedication. Conclusions: This meta-analysis offers evidence for the reduction in the recurrence of moderate and severe HSRs in patients who have a history of such reactions. Premedication with corticosteroids prior to ICM administration is thus highly recommended in high-risk patients.

摘要

目的

过敏反应(HSRs)是CT成像前给予碘化造影剂(ICM)后罕见但严重的不良事件。虽然几乎普遍对高危患者进行预处理,但缺乏关于这种预处理疗效的证据。本研究旨在通过荟萃分析确定在给予ICM之前使用皮质类固醇进行预处理在预防HSRs方面的疗效。材料与方法:广泛的文献综述产生了404项潜在相关研究。其中,五项研究符合本荟萃分析的纳入标准。从每项研究中获取接受和未接受皮质类固醇预处理患者的合并HSR事件发生率。还确定了研究之间的异质性。结果:所有五项研究中的736名患者纳入分析。未接受预处理的患者在所有研究中的初始合并HSR发生率为0.16(95%CI,0.07−0.35)。预处理后,合并HSR发生率降至0.02(95%CI,0.01−0.06)。有既往HSR的患者在接受预处理后发生HSR的可能性显著降低(OR = 0.09;95%CI,0.03−0.25;p < 0.00001)。结论:本荟萃分析为有此类反应病史的患者中重度HSR复发率降低提供了证据。因此,强烈建议高危患者在给予ICM之前使用皮质类固醇进行预处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37f/9320945/da0dbffc8da9/diagnostics-12-01673-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验